Total Viable Bacteria | Total MRSA | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Characteristics (Outcome Measures) | Type of Bedsheets | Mean (viable bacteria) log (CFU·m¯²) with SD | SD error | Log reduction (CFU·m¯²) | Reduction (%) | p-value | Mean (viable bacteria) log (CFU·m¯²) with SD | SD error | Log reduction (CFU·m¯²) | Reduction (%) | p-value |
Overall Study | Ctrl group (n = 144) | 5.72 (± 0.6) | 0.08 | 0.69 | 79.28% | 0.00001§ | 4.21 (± 0.7) | 0.06 | 0.89 | 87.31% | 0.00001§ |
Int group (n = 144) | 5.03 (± 0.7) | 0.09 | 3.31 (± 0.7) | 0.05 | |||||||
Observation Period 1 | Ctrl group (n = 36) | 6.44 (± 0.2) | 0.2 | 0.52 | 69.60% | 0.00001§ | 4.47 (± 0.7) | 0.11 | 1.22 | 94.03% | 0.00001§ |
Int group (n = 36) | 5.93 (± 0.3) | 0.05 | 3.25 (± 0.6) | 0.10 | |||||||
Observation Period 2 | Ctrl group (n = 36) | 5.59 (± 0.6) | 0.10 | 0.65 | 77.88% | 0.00001§ | 4.21 (± 0.7) | 0.12 | 0.82 | 84.82% | 0.00001§ |
Int group (n = 36) | 4.93 (± 0.5) | 0.09 | 3.39 (± 0.6) | 0.11 | |||||||
Observation Period 3 | Ctrl group (n = 36) | 4.21 (± 0.7) | 0.12 | 0.82 | 84.82% | 0.00001§ | 4.18 (± 0.7) | 0.13 | 0.87 | 86.62% | 0.00001§ |
Int group (n = 36) | 3.39 (± 0.6) | 0.11 | 3.30 (± 0.7) | 0.12 | |||||||
Observation Period 4 | Ctrl group (n = 36) | 5.43 (± 0.6) | 0.11 | 0.84 | 85.45% | 0.00001§ | 3.97 (± 0.8) | 0.15 | 0.67 | 78.57% | 0.00001§ |
Int group (n = 36) | 4.59 (± 0.6) | 0.11 | 3.30 (± 0.8) | 0.13 | |||||||
Male Resident’s beds | Ctrl group (n = 72) | 6.02 (± 0.6) | 0.07 | 0.58 | 74.07% | 0.00001§ | 4.34 (± 0.7) | 0.08 | 1.02 | 90.48% | 0.00001§ |
Int group (n = 72) | 5.43 (± 0.6) | 0.08 | 3.32 (± 0.6) | 0.08 | |||||||
Female Resident’s beds | Ctrl group (n = 72) | 5.41 (± 0.5) | 0.07 | 0.79 | 84.12% | 0.00001§ | 4.07 (± 0.8) | 0.09 | 0.77 | 83.07% | 0.00001§ |
Int group (n = 72) | 4.61 (± 0.6) | 0.07 | 3.30 (± 0.7) | 0.08 |